The purpose of this research project is to assess the glycaemic controlling effects of consuming BSG and bio-transformed BSG-containing biscuits and its underlying gut - related mechanism in adults with MetS using in-vivo setting.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in blood glucose concentration
Timeframe: Every 12 week (week 0 and week 12)
Change in insulin concentration
Timeframe: Every 12 week (week 0 and week 12)
Change in blood triglyceride concentration
Timeframe: Every 12 week (week 0 and week 12)
Change in blood cholesterol concentration
Timeframe: Every 12 week (week 0 and week 12)
Change in blood Low-density Lipoprotein-cholesterol (LDL) concentration
Timeframe: Every 12 week (week 0 and week 12)
Change in High-density Lipoprotein-cholesterol (HDL) concentration
Timeframe: Every 12 week (week 0 and week 12)
Change in Hemoglobin A1c (HbA1c) concentration
Timeframe: Every 12 week (week 0 and week 12)
Change in C-reactive protein concentration
Timeframe: Every 12 week (week 0 and week 12)
Change in IL-6 concentration
Timeframe: Every 12 week (week 0 and week 12)
Change in TNF-alpha concentration
Timeframe: Every 12 week (week 0 and week 12)
Change in gut microbiome composition
Timeframe: Every 12 week (week 0 and week 12)
Change in short chain fatty acids concentration
Timeframe: Every 12 week (week 0 and week 12)
Change in bile acid concentration
Timeframe: Every 12 week (week 0 and week 12)